Cellbion

Cellbion is a biotech company in Seoul, South Korea, founded in 2010. It has raised $5.8M across 1 round.

Where Care Meets Innovation, Advancing Radioligand Therapy

Headquarters
Seoul
Employees
51–200
Founded
2010
Business Model
B2B
Total Funding
$5.8M
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

CellBion is a South Korean biopharmaceutical company and pioneer in the radiopharmaceutical industry, founded in 2010, specializing in the development of cutting-edge radioligand therapies to address unmet medical needs in oncology. The company's flagship program is lutetium (177Lu) pocuvotide satetraxetan, a novel PSMA-targeted radioligand therapeutic designed to treat metastatic castration-resistant prostate cancer (mCRPC) by delivering beta-particle radiation selectively to tumor cells while minimizing damage to healthy tissue. With a GMP facility at Seoul National University Cancer Research Institute and an R&D center at Institut Pasteur Korea, CellBion is advancing a differentiated pipeline in theranostics and combination therapies, working toward conditional approval from South Korea's Ministry of Food and Drug Safety.

Summary

It lists 51–200 employees. It has raised $5.8M in total across 1 round.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundPre-IPO Financing
$5.8M

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cellbion on Indexed.vc
<a href="https://indexed.vc/companies/cellbion"><img src="https://indexed.vc/api/badge/company/cellbion" alt="Cellbion on Indexed.vc" width="260" height="76" /></a>